trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Mastocytoma D034801 3 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Ryhänen T et al. Influence of Hsp90 and HDAC inhibition and tubulin acetylation on perinuclear protein aggregation in human retinal pigment epithelial cells. 2011 J. Biomed. Biotechnol. pmid:20981255
Zein S et al. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line. 2010 Exp. Biol. Med. (Maywood) pmid:20975082
El-Serafi AT et al. Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: Differential effects of 5-aza-deoxycytidine and trichostatin A. 2011 Differentiation pmid:20970916
McKenzie L et al. p53-dependent repression of polo-like kinase-1 (PLK1). 2010 Cell Cycle pmid:20962589
Liu YL et al. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. 2010 Autophagy pmid:20962572
Akagi S et al. Treatment with a histone deacetylase inhibitor after nuclear transfer improves the preimplantation development of cloned bovine embryos. 2011 J. Reprod. Dev. pmid:20962457
Gushchina SV et al. [Cellular aspects of regulation of nuclear factor kappaB (NF-kappabeta) transcriptional activity in sensory neurons in vitro]. 2010 Morfologiia pmid:20960709
Simboeck E et al. A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. 2010 J. Biol. Chem. pmid:20952396
Nakaya Y et al. Epigenetic regulation on the 5'-proximal CpG island of human porcine endogenous retrovirus subgroup A receptor 2/GPR172B. 2011 Microbes Infect. pmid:20951222
Gupta PK et al. Inhibitors selective for HDAC6 in enzymes and cells. 2010 Bioorg. Med. Chem. Lett. pmid:20947351
Li Y et al. Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. 2010 Mol. Cancer pmid:20946668
Fernandez G and Zeichner SL Cell line-dependent variability in HIV activation employing DNMT inhibitors. 2010 Virol. J. pmid:20942961
Zhao H et al. New biomarkers probing depth of cell senescence assessed by laser scanning cytometry. 2010 Cytometry A pmid:20939035
Robers MB et al. Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology. 2011 Mol Biosyst pmid:20931131
Milagre I et al. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. 2010 J. Alzheimers Dis. pmid:20930312
Karagiannis TC et al. Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. 2010 Aging (Albany NY) pmid:20930262
Jackson K et al. Epigenetic silencing of somatostatin in gastric cancer. 2011 Dig. Dis. Sci. pmid:20927589
Tan L et al. Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells. 2011 Cancer pmid:20925046
Himaki T et al. Effects of trichostatin A on in vitro development and transgene function in somatic cell nuclear transfer embryos derived from transgenic Clawn miniature pig cells. 2010 Anim. Sci. J. pmid:20887307
Chao KC et al. Anti-tumor activity of histone deacetylase inhibitors and the effect on ATP-binding cassette in ovarian carcinoma cells. 2010 Eur. J. Gynaecol. Oncol. pmid:20882882
Paterson S et al. Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells. 2011 Drug Metab. Dispos. pmid:20870783
Lee CS et al. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines. 2010 Eur. J. Pharmacol. pmid:20868669
Wang X et al. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells. 2010 Blood pmid:20858855
Sengupta S et al. Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. 2011 Oncogene pmid:20856196
Lee MJ et al. Trichostatin A promotes the development of bovine somatic cell nuclear transfer embryos. 2011 J. Reprod. Dev. pmid:20834196
Ji P et al. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. 2010 Haematologica pmid:20823130
Chuang C et al. Acetylation of RNA processing proteins and cell cycle proteins in mitosis. 2010 J. Proteome Res. pmid:20812760
Torres J et al. Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas. 2010 Int. J. Oncol. pmid:20811720
Liu Z et al. Deacetylase inhibitor trichostatin A down-regulates Foxp3 expression and reduces CD4+CD25+ regulatory T cells. 2010 Biochem. Biophys. Res. Commun. pmid:20801101
Kim TH et al. The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice. 2010 Int. Immunopharmacol. pmid:20728595
Sanders YY et al. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. 2011 Am. J. Respir. Cell Mol. Biol. pmid:20724553
Yang F et al. Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize. 2010 BMC Plant Biol. pmid:20718950
Tokoro M et al. Deposition of acetylated histones by RNAP II promoter clearance may occur at onset of zygotic gene activation in preimplantation mouse embryos. 2010 J. Reprod. Dev. pmid:20710121
Lee HS et al. Enhanced histone acetylation in somatic cells induced by a histone deacetylase inhibitor improved inter-generic cloned leopard cat blastocysts. 2010 Theriogenology pmid:20708232
Costa-Borges N et al. Comparison between the effects of valproic acid and trichostatin A on the in vitro development, blastocyst quality, and full-term development of mouse somatic cell nuclear transfer embryos. 2010 Cell Reprogram pmid:20698782
Jichan Nie SW et al. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. 2010 Reprod Sci pmid:20697142
Nam HJ et al. Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation. 2010 J. Biol. Chem. pmid:20696758
Heier CR et al. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. 2010 Hum. Mol. Genet. pmid:20693262
Das ZC et al. Lyophilized somatic cells direct embryonic development after whole cell intracytoplasmic injection into pig oocytes. 2010 Cryobiology pmid:20691649
Sonnemann J et al. Serine proteases in histone deacetylase inhibitor-induced apoptosis. 2010 Mol. Cancer Ther. pmid:20682651
Tamannai M et al. The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells. 2010 Oncol. Res. pmid:20681406
Weng YI et al. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. 2010 Toxicol. Appl. Pharmacol. pmid:20678512
Zhang C et al. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. 2010 J. Hepatol. pmid:20675009
Shahabi S et al. Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells. 2010 Gynecol. Oncol. pmid:20674962
Gay S et al. Nucleotide supply, not local histone acetylation, sets replication origin usage in transcribed regions. 2010 EMBO Rep. pmid:20671737
Kaichi S et al. Cyclin-dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytes. 2011 J. Cell. Physiol. pmid:20665673
Paddock MN et al. The BRCT domain of PARP-1 is required for immunoglobulin gene conversion. 2010 PLoS Biol. pmid:20652015
Shu ST et al. Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. 2010 Anticancer Res. pmid:20651337
Rahman R et al. Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells. 2010 Mol. Cancer Ther. pmid:20643785
Rössler R et al. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. 2010 Neuroscience pmid:20643196
Tian F et al. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons. 2010 Ann. N. Y. Acad. Sci. pmid:20633124
Yang J et al. A novel mechanism involving coordinated regulation of nuclear levels and acetylation of NF-YA and Bcl6 activates RGS4 transcription. 2010 J. Biol. Chem. pmid:20630860
Mizutani H et al. Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide. 2010 Cancer Sci. pmid:20624163
Ma J et al. Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer. 2010 Carcinogenesis pmid:20622005
Mossman D et al. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. 2010 BMC Cancer pmid:20618997
Sharma P et al. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. 2010 Mol. Cancer pmid:20609221
Urbinati G et al. Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy. 2010 Int J Pharm pmid:20603204
Xia J et al. Epigenetic modification of vomeronasal (V2r) precursor neurons by histone deacetylation. 2010 Neuroscience pmid:20594945
Oliveira CS et al. Effects of histone hyperacetylation on the preimplantation development of male and female bovine embryos. 2010 Reprod. Fertil. Dev. pmid:20591338
Zaman MS et al. The functional significance of microRNA-145 in prostate cancer. 2010 Br. J. Cancer pmid:20588276
Luo W et al. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. 2010 Cancer Res. pmid:20587525
Terhune SS et al. Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. 2010 PLoS Pathog. pmid:20585571
Wang XH et al. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. 2010 Am. J. Pathol. pmid:20581057
Xue K et al. Synchronous behaviors of CBP and acetylations of lysine 18 and lysine 23 on histone H3 during porcine oocyte first meiotic division. 2010 Mol. Reprod. Dev. pmid:20575085
Salvi V et al. Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 2010 Sep-Oct Immunobiology pmid:20573419
Kim J et al. PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells. 2010 Mol. Cancer Ther. pmid:20571067
Bo F et al. Effect of trichostatin A on transfected donor cells and subsequent development of porcine cloned embryos. 2011 Zygote pmid:20569515
Legartova S et al. Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors. 2010 Neoplasma pmid:20568903
Trtkova K et al. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB. 2010 Neoplasma pmid:20568894
Han DS et al. Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogen-activated protein kinase pathways. 2010 J. Cell. Biochem. pmid:20568119
Dai X et al. Somatic nucleus reprogramming is significantly improved by m-carboxycinnamic acid bishydroxamide, a histone deacetylase inhibitor. 2010 J. Biol. Chem. pmid:20566633
Kaimori A et al. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes. 2010 Hepatology pmid:20564330
Tessema M et al. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. 2010 Oncogene pmid:20562917
Repouskou A et al. The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells. 2010 Chronobiol. Int. pmid:20560708
Russell SB et al. Epigenetically altered wound healing in keloid fibroblasts. 2010 J. Invest. Dermatol. pmid:20555348
Yoshikawa M et al. Trichostatin a prevents TGF-beta1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells. 2010 Eur. J. Pharmacol. pmid:20553909
Hirata H et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. 2011 Int. J. Cancer pmid:20549706
Kaichi S et al. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. 2010 Cardiovasc. Res. pmid:20547733
Li J et al. Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. 2010 Autophagy pmid:20543569
Alamdari N et al. Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. 2010 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:20538901
Tong JH et al. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. 2010 BMC Cancer pmid:20525238
Kitamoto S et al. Promoter hypomethylation contributes to the expression of MUC3A in cancer cells. 2010 Biochem. Biophys. Res. Commun. pmid:20510874
Liu YW et al. Inhibition of LPS-induced C/EBP delta by trichostatin A has a positive effect on LPS-induced cyclooxygenase 2 expression in RAW264.7 cells. 2010 J. Cell. Biochem. pmid:20506344
Chen J et al. Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes. 2010 Epigenetics pmid:20505343
Kim IA et al. HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? 2010 J. Radiat. Res. pmid:20505264
Bui HT et al. Effect of trichostatin A on chromatin remodeling, histone modifications, DNA replication, and transcriptional activity in cloned mouse embryos. 2010 Biol. Reprod. pmid:20505166
Sudo H and Baas PW Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts. 2010 J. Neurosci. pmid:20505088
Kobori A et al. Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines. 2010 World J. Gastroenterol. pmid:20480520
Estiu G et al. On the inhibition of histone deacetylase 8. 2010 Bioorg. Med. Chem. pmid:20472442
Barua S and Rege K The influence of mediators of intracellular trafficking on transgene expression efficacy of polymer-plasmid DNA complexes. 2010 Biomaterials pmid:20452664
Kiyokawa S et al. New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group. 2010 Bioorg. Med. Chem. pmid:20452226
Ju ZH et al. [Effects of 5-Aza-2'-deoxycitydine and trichostatin A on expression and apoptosis of ALDH1a2 gene in human bladder cancer cell lines]. 2010 Zhonghua Wai Ke Za Zhi pmid:20450613
Zhang D et al. [Effects of trichostatin A on human lung cancer cell strains A549]. 2010 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:20450546
Schuhmann NK et al. Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors. 2010 Exp. Hematol. pmid:20447441
Jeon HW and Lee YM Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression. 2010 Mol. Cancer Ther. pmid:20442303
Zhao TC et al. gp-91 mediates histone deacetylase inhibition-induced cardioprotection. 2010 Biochim. Biophys. Acta pmid:20433879
Marshall H et al. Deficiency of the dual ubiquitin/SUMO ligase Topors results in genetic instability and an increased rate of malignancy in mice. 2010 BMC Mol. Biol. pmid:20429939
Emonds E et al. Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells. 2010 World J. Gastroenterol. pmid:20419833
Yang H et al. Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells. 2010 Exp. Biol. Med. (Maywood) pmid:20404016
Chen WP et al. Trichostatin A inhibits expression of cathepsins in experimental osteoarthritis. 2011 Rheumatol. Int. pmid:20390279